- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
688166
SHH
Week ended 07 Aug 2026
Weekly Investor Report
BrightGene Bio-Medical Technology Co., Ltd. · Healthcare · Biotechnology
Latest close
38.14 CNY
15.8%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -19.8% below the Trend Line and sits at 10.0% of its 52-week range. The latest completed week returned 15.8%, after a 22.3% four-week move. The latest news-sentiment score is 50/100.
Setup score
37
out of 100
Latest Close
38.14 CNY
7 Aug 2026
1W Return
15.8%
latest completed week
4W Return
22.3%
short-term follow-through
12W Return
-38.8%
quarterly tape
Trend Breadth
26.9%
14 of 52 weeks active
Volume Ratio
1.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
15.8%
Latest completed week; four-week move 22.3%.
Indicator stack
15/46
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -19.8% below the Trend Line and sits at 10.0% of its 52-week range. The latest completed week returned 15.8%, after a 22.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1212-week average 0.40
12-week confirmation
Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.12Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 22.3% over four weeks, -38.8% over 12 weeks, and -61.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year14
Trend breadth26.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.47Latest activity-pressure read.
Pressure change58.3%Four-week change in activity pressure.
Leadership-32.57Latest relative-leadership reading.
RS change34.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-68.9%Distance below the 52-week high.
13-week volatility10.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+23.4%Week of 17 Jul.
Worst week-20.5%Week of 26 Jun.
Latest week+15.8%Week of 7 Aug.
Shape of recent returns
Strong gains9
Modest gains2
Flat weeks0
Modest losses5
Sharp losses10
Recent vol10.9%13-week weekly-return volatility.
Base vol9.5%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew6.9% / -7.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorCN Healthcare
4-week rank5 / 100
Group average4.8%
Trend breadth21.0%
Trend21.0%active weekly trend signals
MD64.0%positive activity pressure
RS31.0%positive relative leadership
Four-week leaders
IndustryCN Biotechnology
4-week rank9 / 100
Group average4.5%
Trend breadth15.0%
Trend15.0%active weekly trend signals
MD37.0%positive activity pressure
RS32.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape31/100
Trend, activity pressure, participation, and risk combine to a 31/100 tape read.
Indicator analysis24/100Latest 12-week confirmation: trend 3/12, activity pressure 4/12, relative leadership 0/12.
Activity pressure 0.12; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Enterprise value to EBIT forward of BrightGene Bio-Medical Technology Co. Ltd. Class A – SSE:688166 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 38.14 CNY | 15.8% | 47.55 CNY | 42.22 CNY | -0.47 | -32.57 | 99.8M | Off |
| 31 Jul 2026 | 32.94 CNY | -5.4% | 47.92 CNY | 42.11 CNY | -0.66 | -41.55 | 77.6M | Off |
| 24 Jul 2026 | 34.81 CNY | -9.5% | 48.49 CNY | 42.03 CNY | -0.82 | -39.45 | 125.4M | Off |
| 17 Jul 2026 | 38.48 CNY | 23.4% | 48.95 CNY | 41.95 CNY | -1.05 | -33.47 | 115.3M | Off |
| 10 Jul 2026 | 31.19 CNY | -6.4% | 49.44 CNY | 41.85 CNY | -1.13 | -49.65 | 46.5M | Off |
| 3 Jul 2026 | 33.31 CNY | -3.1% | 50.13 CNY | 41.79 CNY | -1.00 | -47.40 | 9.6M | Off |
| 26 Jun 2026 | 34.36 CNY | -20.5% | 50.77 CNY | 41.72 CNY | -0.77 | -46.01 | 11.1M | Off |
| 19 Jun 2026 | 43.21 CNY | -1.9% | 51.26 CNY | 41.64 CNY | -0.34 | -33.86 | 52.9M | Off |
| 12 Jun 2026 | 44.03 CNY | -6.9% | 51.64 CNY | 41.51 CNY | 0.04 | -32.12 | 13.5M | Off |
| 5 Jun 2026 | 47.28 CNY | -8.7% | 51.95 CNY | 41.37 CNY | 0.54 | -27.42 | 9.5M | On |
| 29 May 2026 | 51.77 CNY | -9.6% | 52.29 CNY | 41.21 CNY | 0.98 | -21.67 | 58.5M | On |
| 22 May 2026 | 57.28 CNY | -8.1% | 52.34 CNY | 41.01 CNY | 1.24 | -14.45 | 48.7M | On |
| 15 May 2026 | 62.35 CNY | -6.4% | 52.14 CNY | 40.79 CNY | 1.41 | -7.46 | 64.6M | On |
| 8 May 2026 | 66.62 CNY | 5.6% | 51.95 CNY | 40.54 CNY | 1.46 | -2.17 | 51.2M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.